Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00330473 · ClinicalTrials.gov registry record · Phase 3
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,019
- Enrollment target
NCT00330473: Completed Phase 3 study, sponsored by Eli Lilly and Company.
NCT00330473 is a Phase 3 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 1,019 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (32% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00330473, a Phase 3 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,019 participants
- Enrollment target
Study Summary
A study to compare insulin use and its effect on glucose control and other outcomes in patients with Type 2 diabetes who together with their healthcare provider manage their disease by discussing and agreeing on the diabetes treatment chosen from a selection of available treatment options.
Interventions
- DRUG Insulin
- DRUG Human Insulin Inhalation Powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,019 participants |
| Start Date | 2006-06 |
| Est. Completion | 2008-05 |
| Phase | Phase 3 |
What the finished NCT00330473 record still lists
NCT00330473 is an interventional study that assigns participants to a tested intervention. Its 1,019 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (32% higher).
The record links to 0 conditions, and to 2 interventions - of which Insulin is the first listed.
NCT00330473 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00330473 about?
NCT00330473 is a clinical study titled "A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes". A study to compare insulin use and its effect on glucose control and other outcomes in patients with Type 2 diabetes who together with their healthcare provider manage their disease by discussing and agreeing on the diabetes treatment chosen from a selection of available treatment options.
What is the current status of trial NCT00330473?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,019 participants. The study started on 2006-06. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00330473?
The interventions under investigation include: Insulin (DRUG), Human Insulin Inhalation Powder (DRUG).
Who is sponsoring clinical trial NCT00330473?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00330473's enrollment target sits among peer trials
1,019 293rd of 2000 higher than 1,708 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02178163 · 1,020 participants · NA
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
- NCT05225428 · 1,020 participants · NA
Video Education With Result Dependent dIsclosure
- NCT06697600 · 1,020 participants · NA
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
- NCT06760637 · 1,020 participants · Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia